GenMark Diagnostics Inc. (GNMK) announced after the bell Monday that it now expects to report full year 2013 revenues of approximately $30 million, down from its original estimate of approximately $35 million. The consensus estimate is for revenues of $35.11 million. The stock is now down 0.72 on 36K shares.
GenMark Diagnostics traded to the downside throughout Monday's session and finished lower by 1 point at $10.97. The stock has been steadily declining for the past week.
For comments and feedback: editorial@rttnews.com